TY - JOUR
AU1 - 
AB - Circulation JOURNAL OF THE AMERICAN HEART ASSOCIATION Vol 114, No 8, August 22, 2006 RISK OF THROMBOEMBOLIC EVENTS AFTER RANDOMIZED, DOUBLE-BLIND, MULTICENTER PERCUTANEOUS LEFT ATRIAL STUDY OF THE ENDEAVOR ZOTAROLIMUS- RADIOFREQUENCY ABLATION OF ATRIAL ELUTING PHOSPHORYLCHOLINE- FIBRILLATION, by Oral et al. ENCAPSULATED STENT FOR TREATMENT OF NATIVE CORONARY ARTERY LESIONS: In patients with atrial fibrillation (AF), thromboembolism and CLINICAL AND ANGIOGRAPHIC RESULTS OF the need for anticoagulation influence the risks and benefits of THE ENDEAVOR II TRIAL, by Fajadet et al. catheter ablation for maintaining sinus rhythm. Ablation has a risk of thromboembolism. After a successful procedure, with- The efficacy of drug-eluting stents (DES) has been demon- drawal of anticoagulation would be attractive to many pa- strated in a number of clinical trials. In these studies, DES have been shown to decrease the rates of clinical and angio- tients, but there are limited data on the safety of this approach. Oral and colleagues examined these issues in a 755 consec- graphic restenosis observed with bare metal stents from 20% utive patients with AF. They observed a 1.1% risk of throm- to 40% to single-digit numbers. Moreover, long-term boembolism during the first few weeks after catheter ablation. follow-up has shown 
TI - Issue Highlights
JF - Circulation
DA - 2006-08-01
UR - https://www.deepdyve.com/lp/wolters-kluwer-health/issue-highlights-TPZ0RK00Pd
SP - 753
EP - 753
VL - 114
IS - 8
DP - DeepDyve
ER -